A local audit evaluating bone health in patients with functional hypothalamic amenorrhoea secondary to an eating disorder and a review of the application of hormone therapy in this clinical setting
Post Reproductive Health · 2024
DOI: 10.1177/20533691241261749 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Post Reproductive Health, 2024. Verfasst von Hannah Olivia Davies. Beteiligte Einrichtung: Primary Care, Mid and South Essex NHS Foundation Trust, Leigh-on-Sea, UK. Hauptthemen laut MEDLINE: Amenorrhea, Feeding and Eating Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
It is widely known that estrogen has a fundamental role to play in skeletal homeostasis. In the most reductionist sense, the action of estrogen can be surmised as anti-resorptive. Estrogen prevents the break-down of bone. It therefore follows that estrogen deficiency states, such as the menopause and functional hypothalamic amenorrhoea (FHA), are often characterised by increased bone remodelling and disrupted skeletal homeostasis. FHA is the cessation of menstruation secondary to abnormal signalling between the hypothalamus and pituitary gland due to deficient pulsatile secretion of Gonadotrophin Releasing Hormone (GnRH). Functional hypothalamic amenorrhoea is frequently a consequence of women suffering with eating disorders. The development of FHA secondary to eating disorders is an evolutionary adaptive response to chronic metabolic energy deficiency. Fundamentally, preservation of life is biologically prioritised over dispensable physiological process such as reproduction. Consequently, the hypothalamic-pituitary-ovarian (HPO) axis fails, which disrupts menstrual function and ovulation, culminating in a state of estrogen deficiency. One of the most important and long-lasting deleterious consequences of FHA is disrupted skeletal homeostasis and bone loss. Estrogen replacement, most commonly in the form of combined hormone replacement therapy (HRT) or the combined oral contraceptive pill (COCP), is advised for women with an early menopause to prevent bone loss. Arguably, estrogen replacement should also be utilised in the context of FHA. However, the optimum estrogen regime for women with FHA remains under-researched and so management is not evidence-based.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Primary Care, Mid and South Essex NHS Foundation Trust, Leigh-on-Sea, UK.
ORCID-Profile: Hannah Olivia Davies
Zitieren
APA
Davies, H. O. (2024). A local audit evaluating bone health in patients with functional hypothalamic amenorrhoea secondary to an eating disorder and a review of the application of hormone therapy in this clinical setting. Post Reproductive Health. https://doi.org/10.1177/20533691241261749
Vancouver
Davies HO. A local audit evaluating bone health in patients with functional hypothalamic amenorrhoea secondary to an eating disorder and a review of the application of hormone therapy in this clinical setting. Post Reproductive Health. 2024. doi:10.1177/20533691241261749
BibTeX
@article{Davies2024,
author = {Davies, Hannah Olivia},
title = {A local audit evaluating bone health in patients with functional hypothalamic amenorrhoea secondary to an eating disorder and a review of the application of hormone therapy in this clinical setting},
journal = {Post Reproductive Health},
year = {2024},
doi = {10.1177/20533691241261749}
}
EUVIMED